Browsing by Author "Fagan, J."

Now showing items 1-2 of 2

A first New Zealand study looked at the role of lutetium-177-P SMA I &T in the progression of metastatic castrate-resistant prostate cancer

Vyas, Madhusudan; Garett, N.; Lim, R.; Fagan, J. (2021-11)

Prostate cancer that has spread beyond the prostate gland and is resistant to castration is a deadly disease that poses a threat to men's health. The current standard of care for metastatic prostate cancer is hormonal ...
Lutetium-177-PSMA I&T for progressing metastatic castrate-resistant prostate cancer : a single NZ centre experience

Vyas, Madhusudan; Fagan, J.; Lim, R.; Garett, N. (2020-10)

Objectives Metastatic Castration resistant prostate cancer (mCRPC) Metastatic Castration resistant prostate cancer (mCRPC) and PSMA Various PSMA ligands and radionuclidessuitable for labelling Lu177-PSMA and Mechanism ...